|
|
|
|
|
The Niche
|
Stem Cell & Regenerative Med Newsletter
|
|
|
|
|
|
Recommended reads: Bik, FDA letter, gecko cancer model, David Baltimore on COVID origin
|
|
|
|
What can a gecko possibly teach us about skin cancer? Read on. It's fun when a week's worth of science reading covers so much territory including COVID-19, geckos that get cancer, a research misconduct sleuth, an FDA letter, and more. Baltimore weighs in on COVID lab origin idea Caltech has a very interesting interview with David Baltimore on the possible …
|
|
|
|
|
|
|
|
Quick reaction to milestone ViaCyte data on a diabetes patient
|
|
|
|
ViaCyte released encouraging data just now on a patient with implanted stem cell-derived pancreas-like device whose diabetes improved. You can read more about this in the Endpoints piece that I linked to in the previous sentence. Stem cells for diabetes; the ViaCyte update The idea of stem cells for diabetes has been more on my mind in part because I …
|
|
|
|
|
|
|
|
Stem cell therapy for diabetes updates: expected IPO, CRISPR, new pubs, more
|
|
|
|
The idea of stem cell therapy for diabetes is both exciting and in a way practical. By that I mean that there's a good common sense foundation here. The idea of stem cell therapy for diabetes What do I mean? If medical researchers can replace lost beta cells in the pancreas using stem cell-produced beta cells, diabetes might be effectively …
|
|
|
|
|
|
